Propanc Health (PPCH) 0.0439 $PPCH Propanc Health Group

New Post Public Reply Private Reply Replies (0) Message Board

Oct 10, 2015 at 9:14 AM

Propanc Health (PPCH) 0.0439 $PPCH

Propanc Health Group Shares Jump 22% - BrokerBank Securities Provides Insights
PR Newswire - Wed Oct 07, 7:00AM CDT
Propanc Health Group Corp. (OTCQB: PPCH) shares closed at $.0426 yesterday, up 22%. Trading volume was over double the average at 11 million shares. PPCH shares have risen 90% since they hit a low of $.0225 On September 29th.

This Company Could Be the Next CETX or CANF
ACCESSWIRE - Mon Oct 05, 9:02AM CDT
LAS VEGAS, NV / ACCESSWIRE / October 5, 2015 / What do Cemtrex, Inc. (CETX) and Can-Fite BioPharma Ltd. (CANF) have in common? They both made investors boatloads of money over the past month, with 100 and 200% moves respectively. That and they both remind us of Propanc Health Group Corporation (PPCH).
CANF: 4.20 (-0.07)

Propanc Secures Financing to Complete Preclinical Animal Studies and Progress Company towards Human Trials; Updates on Progress and Plans
ACCESSWIRE - Thu Oct 01, 7:01AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / October 1, 2015 / Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic and colorectal cancers, today announced a summary of current activities and recent achievements which will see the Company ready to complete several important milestones in the coming months.

Biotech Companies with Great Potential
ACCESSWIRE - Tue Sep 22, 3:14PM CDT
LAS VEGAS, NV / ACCESSWIRE / September 22, 2015 / Microcapspeculators.com is an informational website that is highly interested in exploring development stage companies, en route to finding companies with the best potential. Our main sectors of interest include technology, and biotech companies.

The NASDAQ Biotech Index Is Partying Like It's 1999 - Some Say The Party's Just Getting Started, Some Say We're At The Top
ACCESSWIRE - Mon Aug 24, 4:10PM CDT
WINDSOR, ON / ACCESSWIRE / August 24, 2015 / The Wealthy Biotech Trader (or "WBT"

, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, would like to discuss some recent explosions in share price of two biotech stocks and two biotech Company's which have pending news which could serve as catalysts to potentially move their stocks.
IYH: 144.07 (+0.83), SPY: 201.33 (+0.12), AQXP: 12.90 (+0.11), ANTH: 6.12 (+0.12), ONCS: 4.30 (-0.04)

Propanc Identifies Potential Patent Opportunities
ACCESSWIRE - Thu Aug 13, 8:58AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / August 13, 2015 / Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic and colorectal cancers, today announced that the Company has identified potential patent opportunities as a result of the ongoing research and development activities underway with its research partners.

Propanc Up-lists to OTCQB; Reduces Authorized Shares by 80%
ACCESSWIRE - Tue Aug 04, 7:30AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / August 4, 2015 / Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic and colorectal cancers, today announced the Company recently commenced trading on the OTCQB Marketplace, and confirms it continues to file periodic reports under Section 15(d) of the Exchange Act.

Propanc Identifies Positive Signals for Efficacy from Pilot Animal Studies
ACCESSWIRE - Thu Jul 09, 8:46AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 9, 2015 / Propanc Health Group Corporation (PINKSHEETS: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that positive signals have emerged in several pilot animal studies measuring the effects of PRP against several tumor types.

Propanc Enters into Research Agreement with Adaptive Biotechnologies
ACCESSWIRE - Mon Jul 06, 11:40AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / July 6, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced that it has entered into a biomarker discovery agreement with Adaptive Biotechnologies, Seattle, WA, USA.

The Wealthy Biotech Trader's New Feature Pick Runs Over 150% After Announcement - Traders are Calling it the Next PPCH 3,200%+ Runner
ACCESSWIRE - Thu Jun 25, 10:42AM CDT
WINDSOR, ON / ACCESSWIRE / June 25, 2015 / The Wealthy Biotech Trader (or "WBT"

, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the recent move PositiveID (OTC: PSID) has made in the market. WBT reiterates PositiveID (OTC: PSID) as their pick for the summer and into the fall.
ADXS: 11.07 (+0.83)

Penny Stocks Alerts for TOTALLY HEMP CRAZY, TapImmune, Root9b Technologies, EKSO BIONICS HOLDING, Propanc Health Group, and Dominovas Energy
PR Newswire - Thu Jun 25, 7:49AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TOTALLY HEMP CRAZY (OTCMKTS:THCZ), TapImmune (OTCMKTS:TPIV), Root9b Technologies (OTCMKTS:RTNB), EKSO BIONICS HOLDING (OTCBB:EKSO), Propanc Health Group (OTCMKTS

PCH), and Dominovas Energy (OTCMKTS

NRG).

Propanc Provides Shareholder Update
ACCESSWIRE - Fri Jun 19, 7:52AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 19, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced a summary of Corporate and R&D activities currently underway as part of a shareholder update since presenting at the SeeThru Equity Conference last month.

Penny Stocks Recap for Propanc Health Group, Arrayit Corp, PositiveID, TapImmune, TOTALLY HEMP CRAZY, and Medican Enterprises
PR Newswire - Fri Jun 19, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Propanc Health Group (OTCMKTS

PCH), Arrayit Corp (OTCMKTS:ARYC), PositiveID (OTCMKTS

SID), TapImmune (OTCMKTS:TPIV), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), and Medican Enterprises (OTCMKTS:MDCN).

Propanc Settles Two Outstanding Convertible Debts
ACCESSWIRE - Thu Jun 18, 7:31AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / June 18, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company repaid two outstanding convertible notes as part of its plans to reduce overall debt.

Three Companies with the Ingredients to Follow in the Footsteps of Advaxis (NASDAQ: ADXS)
ACCESSWIRE - Tue Jun 16, 2:34PM CDT
WINDSOR, ON / ACCESSWIRE / June 16, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves, would like to report on the seldom huge potential of the OTC market when used as a proper stepping-stone to a national stock exchange.
ADXS: 11.07 (+0.83)

Penny Stocks Research for Hangover Joe's, Terra Tech, TOTALLY HEMP CRAZY, Medican Enterprises, Propanc Health Group, and MaryJane Group
PR Newswire - Thu Jun 11, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Hangover Joe's (OTCMKTS:HJOE), Terra Tech (OTCMKTS:TRTC), TOTALLY HEMP CRAZY (OTCMKTS:THCZ), Medican Enterprises (OTCMKTS:MDCN), Propanc Health Group (OTCMKTS

PCH), and MaryJane Group (OTCMKTS:MJMJ).

Propanc Briefs Investors at the SeeThruEquity 4th Annual Investor Conference
ACCESSWIRE - Fri May 29, 10:47AM CDT
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 29, 2015 / Propanc Health Group Corporation (OTCPK: PPCH) ("Propanc" or "the Company"

, an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company briefed investors at the SeeThruEquity 4th Annual Microcap Investor Conference, held at the Convene Grand Central, Midtown Manhattan, New York, on Thursday, May 28th.

SeeThruEquity Initiates Coverage on Propanc Health Group with a Price Target of $1.52
ACCESSWIRE - Wed May 27, 9:12AM CDT
NEW YORK, NY / ACCESSWIRE / May 27, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Propanc Health Group Corp.. (PINKSHEETS: PPCH) with a Price Target of $1.52.

Corrected Article - The Road To The Cure: 4 Biotech Stocks Advancing New Therapies In The Fight Against Cancer
ACCESSWIRE - Tue May 19, 4:00PM CDT
WINDSOR, ON / ACCESSWIRE / May 19, 2015 / The Wealthy Biotech Trader, an Investment Newsletter focused on showing everyday Investors new opportunities in rapidly growing, little-known, Biotech stocks making news and subsequent market moves.
VSTM: 1.93 (-0.05), CERU: 3.65 (+0.07), PPHM: 1.07 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A. O. Smith Reports Q3 2026: A Strategic Shift

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...

ACCULOAD: Aiming for Safer, Easier Boat Loading

Getting a boat onto a trailer? It can turn into a circus act if you're not careful. Visibility's shot, conditions change faster than a stock ticker, and alignment's like threading a needle blindfolded. Out comes ACCULOAD, a novel idea created by some intrepid inventor down in Slocomb, Ala, aiming to solve what’s been a pain point for boaters worldwide. What's ACCULOAD...

USD 6.8 Million for Disease R&D: GHIT's Bold Bet

GHIT Fund Pumps Millions Into Health R&D In a world plagued by infectious disease outbreaks and continual health challenges, the Global Health Innovative Technology (GHIT) Fund isn't just twiddling its thumbs—they're throwing down around $6.8 million to wrestle some of the nastiest bugs out there, like malaria and Ebola. This cash doubles down on nine risky gambles,...

Randi Cruz Steps Up as CFO at Bridge Legal

A Key Milestone for Bridge Legal Here's a juicy tidbit for you: Bridge Legal is shaking things up by promoting Randi Cruz to Chief Financial Officer. It's a big deal, folks, especially when you consider that this company is one of those movers and shakers in the legal tech world. Randi's journey at Bridge Legal hasn't been a walk in the park, but more of a strategic...

NEO Battery's Quarter: Converting Leads to Contracts

NEO Battery's Bold Moves A glance at NEO Battery Materials Ltd.'s latest update feels like reading the playbook of a team stepping it up a notch. They're pushing those silicon-enhanced wonders into new territories—and doing so with one eye on expansion and the other on severe demand spikes from high-stakes sectors. From Leads to Customers No one's gonna raise eyebrows...

Luxury Travel Spikes While Budget Trips Take a Hit

Luxury Trips on The Uptrend Luxury travel is surging while budget trips are taking a backseat. According to Squaremouth's latest data, high-end getaways insured for a whopping $30,000 or more shot up by 27.2% in the third quarter of 2026 compared to the same time last year. In contrast, budget-friendly jaunts under $10,000 dipped by 2.3%. Travelers seem ready to splurge...

Rongtao Maps New Rules for Ultrasound Part Compliance

Navigating the Compliance Maze for Ultrasound Parts Just when you think you've figured out the rules, there's a new twist. Rongtao Medical is diving headfirst into the convoluted world of the EU Medical Device Regulation (MDR), and they're mapping out the maze for ultrasound replacement parts. Now, anyone dabbling in this sector better pay attention because things are...

LG Energy Sparks Global Innovation with BIC 2026

Innovating Beyond Boundaries with LG Energy The world of battery tech is on fire, and LG Energy Solution is fanning the flames with their Battery Innovation Contest 2026 (BIC 2026). From October 29 to December 6, 2026, universities and research hives across the globe are being beckoned to pour their battery brilliance into this contest. These aren't just any research...

ID Plans Secures Polaris Investment for Real Estate Boost

New Moves in Real Estate Tech Can you smell opportunity? Because it’s in the air down in Tampa where ID Plans just inked a deal with Polaris Growth Fund. We’re talking some serious private equity backing here aimed at ramping up what ID Plans can lay down in the commercial real estate sector. If you're not on this ride yet, it might be time to take a closer look....

CATL's Bold Move: New Energy Storage Game Changer

Fresh Energy on the Aussie Horizon Ever see a heavyweight step into the ring and know it's about to shake things up? That's CATL breaking into Australia with their new TENER+ system. This ain't just talk—these guys are delivering ultra-high capacity energy storage aimed right at the heart of the Australian energy sector, just in time for All Energy 2026. A Big Play in...